Navegando por Palavras-chave "Tongue stabilizing device"

Agora exibindo 1 - 1 de 1
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Tratamento dos distúrbios respiratórios do sono com retentor lingual: ensaio clínico randomizado cross-over
    (Universidade Federal de São Paulo (UNIFESP), 2018-12-20) Jung, Aline [UNIFESP]; Prado, Gilmar Fernandes do [UNIFESP]; Machado, Marco Antônio Cardoso [UNIFESP]; Prado, Lucila Bizari Fernandes do [UNIFESP]; http://lattes.cnpq.br/3844314810128616; http://lattes.cnpq.br/9922055566135433; http://lattes.cnpq.br/2617510083171521; http://lattes.cnpq.br/0793635204250482; Universidade Federal de São Paulo (UNIFESP)
    Objective. Check the efficiency of the dental appliance retainer lingual TSD (Tongue Stabilizing Device) in the treatment of Obstructive Sleep Apnea Syndrome (OSAS). Method. Randomized Clinical Trial Cross-over 64 patients with polysomnographic diagnosis of obstructive sleep apnea. Patients were randomized into two groups, one treated with TSD and another treated with acetate plate as control (CG) for 4 weeks. After 2 weeks of wash-out, the treatments were exchanged and the patients used the new device for 4 weeks. They were assessed with polysomnography, daily use and adverse events. Results: Patients who used the TSD device compared to control group had lower apneahypopnea index (AHI) (11.5±10.6 events/hour versus 14.8±11.7 events/hour, p <0.05), and more discontinuing use because of adverse events (18 patients, 28,1% versus 1 patient, 1.6%; p <0.05). Of the patients treated with TSD, 25 (39%) had a reduction in AHI and 14 (22%) patients reduced AHI to less than 5. TSD patients younger than 56 years compared to those older than 56 years had a lower AHI (8.1 ± 5.9 events/hour versus AHI 14.9 ± 13.4 events/hour, p <0.05), higher TTS (357.4 ± 64.8min versus 323.1 ± 48.8min; p <0.05) and better sleep efficiency (84.2 ± 9.7% versus 77.3 ± 7.4%, p <0.05). Conclusion: The treatment of mild and moderated OSA with TSD is an option that can benefits only a few number of patients. The reduction of respiratory events in the treated group was small, and only a fifth of the patients normalized the number of the events. The TSD connected to side effects that motivated the suspension of a high number of the patients.